Interleukin-7 levels may predict virological response in advanced HIV-1-infected patients receiving lopinavir/ritonavir-based therapy

HIV Medicine

Volumn 4, Issue 4, 2003, Pages 315-320

  Boulassel, M R ^a   Smith, G H R ^a   Gilmore, N ^a   Klein, M ^a   Murphy, T ^a   MacLeod, J ^a   LeBlanc, R ^a   Allan, J ^a   Rene P ^a   Lalonde, R G ^a   Routy, Jean Pierre ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Antiretroviral therapy; HIV; Immune reconstitution; Interleukin 7; Predictive value

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; INTERLEUKIN 7; LOPINAVIR PLUS RITONAVIR; MEMBRANE ANTIGEN; PROTEINASE INHIBITOR; SAQUINAVIR;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MEDICAL ASSESSMENT; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; T LYMPHOCYTE; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INTERLEUKIN-7; LYMPHOCYTE COUNT; MALE; PROSPECTIVE STUDIES; PYRIMIDINONES; RITONAVIR; T-LYMPHOCYTES; VIRAL LOAD;

EID: 0142186255     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1293.2003.00165.x     Document Type: Article

References (18)

1. Lederman MM, Valdez H. Immune restoration with antiretroviral therapies: implications for clinical management. J Am Med Assoc 2000; 284: 223-828.
2. Lyman SD, Jacobsen SE. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998; 91: 1101-1134.
3. Merchav S. The haematopoietic effects of growth hormone and insulin-like growth factor-I. J Pediatr Endocrinol Metab 1998; 11: 677-685.
4. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood 2002; 99: 3892-3904.
5. Bolotin E, Annett G, Parkman R, Weinberg K. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 1999; 23: 783-788.
6. Napolitano LA, Grant RM, Deeks SG et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001; 7: 73-79.
7. Fry TJ, Connick E, Falloon J et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001; 97: 2983-2990.
8. Darcissac EC, Vidal V, De La Tribonniere X, Mouton Y, Bahr GM. Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy. Clin Exp Immunol 2000; 126: 287-294.
9. Walmsley S, Bernstein B, King M et al. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med 2002; 346: 2039-2046.
10. Benson CA, Deeks SG, Brun SC et al. Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients. J Infect Dis 2002; 185: 599-607.
11. Llano A, Barretina J, Gutierrez A et al. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J Virol 2001; 75: 10319-10325.
12. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 1998; 91: 75-88.
13. Viard JP, Mocroft A, Chiesi A et al. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis 2001; 183: 1290-1294.
14. MacPherson PA, Fex C, Sanchez-Dardon J, Hawley-Foss N, Angel JB. Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 28: 454-457.
15. Vingerhoets J, Bisalinkumi E, Penne G et al. Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol Lett 1998; 61: 53-61.
16. Steffens CM, Managlia EZ, Landay A, Al-Harthi L. Interleukin-7-treated naive T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood 2002; 99: 3310-3318.
17. Miller V, Phillips AN, Clotet B et al. Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts. J Infect Dis 2002; 186: 189-197.
18. Paredes R, Mocroft A, Kirk O et al. Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med 2000; 160: 1123-1132.